SPARKee Dr. Shirit Einav featured in New Yorker piece on antivirals for pandemics
Posted on April 24th, 2020
A recent New Yorker article looks at the challenge and efforts to develop antivirals for the current coronavirus and future pandemics. The story features SPARK scholar Dr. Shirit Einav, a virologist focusing on host-targeted drugs as broad antivirals. Dr. Einav and colleagues are testing drugs against SARS-CoV-2 that previously showed promise against dengue and Ebola by slowing replication.